Skip to main content
SpringerLink
Log in

Palliative Chirurgie des Ösophaguskarzinoms

  • Chapter
  • First Online:
Palliative Viszeralchirurgie

  • 1392 Accesses

Zusammenfassung

Ösophaguskarzinome stellen ≥ 99 % aller primären Malignome der Speiseröhre dar. Neben den beiden häufigsten Subentitäten (Adeno- und Plattenepithelkarzinome) treten, wenn auch wesentlich seltener neuroendokrine Karzinome (≤ 1 %) auf. Die studienbasierte Entwicklung multimodaler Therapiealgorithmen hat zu einer deutlichen Verbesserung der Prognose, insbesondere bei Plattenepitelkarzinomen beigetragen. Dennoch zählen Speiseröhrenkarzinome zu den Krebserkrankungen mit einer weiterhin schlechten Prognose und vergleichsweise hohen Mortalität.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • A study of MLN0264 in participants with cancer of the stomach or gastroesophageal Junction. ClinicalTrials.gov Identifier: NCT02202759

  • Al-Batran SE, Homann N, Pauligk C et al (2017) Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial. JAMA Oncol 3(9):1237–1244. https://doi.org/10.1001/jamaoncol.2017.0515

    Article  Google Scholar 

  • Andreou A, Viganò L, Zimmitti G et al (2014) Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer. J Gastrointest Surg 18(11):1974–1986. https://doi.org/10.1007/s11605-014–2623-0

    Article  PubMed  Google Scholar 

  • Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376(9742):687–697. https://doi.org/10.1016/S0140-6736(10)61121-X. Epub 2010 Aug 19

    Article  CAS  PubMed  Google Scholar 

  • Bhatt L, Tirmazy S, Sothi S (2013) Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center. Dis Esophagus 26(1):57–60. https://doi.org/10.1111/j.1442–2050.2012.01333.x

    Article  CAS  PubMed  Google Scholar 

  • Chemotherapy alone vs. chemotherapy + surgical resection in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction (FLOT5). ClinicalTrials.gov Identifier: NCT02578368

  • Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281(17):1623–1627

    Article  CAS  Google Scholar 

  • Cormier JN, Xing Y, Yao J et al (2009) Attempted salvage resection for recurrent gastric or gastroesophageal cancer. Ann Surg Oncol 16(1):42–50. https://doi.org/10.1245/s10434-008-0210-x. Epub 2008 Nov 5

    Article  PubMed  Google Scholar 

  • Cytoreductive Surgery (CRS) with/without HIPEC in gastric cancer with peritoneal carcinomatosis (GASTRIPEC). ClinicalTrials.gov Identifier: NCT02158988

  • D’Journo XB, Berbis J, Jougon J et al (2017) External validation of a risk score in the prediction of the mortality after esophagectomy for cancer. Dis Esophagus 30(1):1–8. https://doi.org/10.1111/dote.12447

    Article  PubMed  Google Scholar 

  • Fakhrian K, Gamisch N, Schuster T et al (2012) Salvage radiotherapy in patients with recurrent esophageal carcinoma. Strahlenther Onkol 188(2):136–142. https://doi.org/10.1007/s00066-011-0023-x

    Article  CAS  PubMed  Google Scholar 

  • Fuchs HF, Harnsberger CR, Broderick RC et al (2017) Simple preoperative risk scale accurately predicts perioperative mortality following esophagectomy for malignancy. Dis Esophagus 30(1):1–6. https://doi.org/10.1111/dote.12451

    Article  CAS  PubMed  Google Scholar 

  • Gabriel E, Attwood K, Shah R et al (2017) Novel calculator to estimate overall survival benefit from neoadjuvant chemoradiation in patients with esophageal adenocarcinoma. J Am Coll Surg 224(5):884–894.e1. https://doi.org/10.1016/j.jamcollsurg.2017.01.043. Epub 2017 Jan 29

    Article  PubMed  PubMed Central  Google Scholar 

  • Gadde R, Tamariz L, Hanna M et al (2015) Metastatic gastric cancer (MGC) patients: can we improve survival by metastasectomy? A systematic review and meta-analysis. J Surg Oncol 112(1):38–45. https://doi.org/10.1002/jso.23945

    Article  PubMed  Google Scholar 

  • Glehen O, Gilly FN, Arvieux C et al (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17(9):2370–2377. https://doi.org/10.1245/s10434-010-1039-7

    Article  PubMed  Google Scholar 

  • Homs MY, Steyerberg EW, Eijkenboom WM et al (2004b) Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364(9444):1497–1504

    Article  Google Scholar 

  • Homs MY, Essink-Bot ML, Borsboom GJ et al (2004a) Quality of life after palliative treatment for oesophageal carcinoma – a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer 40(12):1862–1871

    Article  Google Scholar 

  • Markar S, Gronnier C, Duhamel A et al (2015) Salvage surgery after chemoradiotherapy in the management of esophageal cancer. Is it a viable therapeutic option? J Clin Oncol 33(33):3866–3873. https://doi.org/10.1200/JCO.2014.59.9092

    Article  CAS  PubMed  Google Scholar 

  • Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20(5):1167–1174

    Article  CAS  Google Scholar 

  • Neri A, Marrelli D, Voglino C et al (2016) Recurrence after surgery in esophago-gastric junction adenocarcinoma: current management and future perspectives. Surg Oncol 25(4):355–363. https://doi.org/10.1016/j.suronc.2016.08.003. Epub 2016 Aug 16

    Article  PubMed  Google Scholar 

  • Oyama K, Fushida S, Kinoshita J et al (2012) Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes. J Surg Oncol 105(6):535–541. https://doi.org/10.1002/jso.22125

    Article  CAS  PubMed  Google Scholar 

  • S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus (AWMF-Registernummer: 021/0230L)

    Google Scholar 

  • Scaringi S, Kianmanesh R, Sabate JM et al (2008) Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. Eur J Surg Oncol 34(11):1246–1252. https://doi.org/10.1016/j.ejso.2007.12.003

    Article  CAS  PubMed  Google Scholar 

  • Schipper PH, Cassivi SD, Deschamps C et al (2005) Locally recurrent esophageal carcinoma: when is re-resection indicated? Ann Thorac Surg 80(3):1001–1005

    Article  Google Scholar 

  • Yonemura Y, Kawamura T, Bandou E et al (2005) Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 92(3):370–375

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Allgemein-, Viszeral- und Tumorchirurgie, Uniklinik Köln, Köln, Deutschland

    Markus Ghadimi & Christiane J. Bruns

Authors
  1. Markus Ghadimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christiane J. Bruns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Markus Ghadimi .

Editor information

Editors and Affiliations

  1. Universitätsmedizin Göttingen, Klinik für Allgemein-, Viszeral- und Kinderchirurgie, Göttingen, Germany

    Michael Ghadimi

  2. Klinik für Allgemein, Viszeral- und Gefäßchirurgie, DRK-Kliniken Nordhessen, Kassel, Germany

    Kia Homayounfar

  3. Klinik und Poliklinik für Allgemein-, Universitätsklinikum Bonn Klinik und Poliklinik für Allgemein-, Bonn, Germany

    Jörg C. Kalff

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ghadimi, M., Bruns, C.J. (2019). Palliative Chirurgie des Ösophaguskarzinoms. In: Ghadimi, M., Homayounfar, K., Kalff, J. (eds) Palliative Viszeralchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57362-4_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57362-4_17

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57361-7

  • Online ISBN: 978-3-662-57362-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation